A Michigan University clinical researcher allegedly supplied a fund manager with information about drug trial results that the fund used to rake in more than $270 million.
The Scientist
Most Recent
The European Commission approves the Western hemisphere’s first gene therapy, aimed at correcting a lipid-processing disorder.
New noninvasive methods of selecting the most viable embryo could revolutionize in vitro fertilization.
Contributors
| November 1, 2012
Meet some of the people featured in the November 2012 issue of The Scientist.
After two headline successes, companies rush to develop “smart bomb” cancer drugs.
Large RNA-protein packets use a novel mechanism to escape the cell nucleus.
Understanding the mechanism of a classic tuberculosis treatment could refine future strategies for TB drug development.
Swapping chromosomes from one human egg to another could eliminate mitochondrial DNA mutations that cause disease.
Keith Campbell, a biologist who was part of the effort to clone Dolly the sheep, has passed away at the age of 58.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
